دورية أكاديمية
أعرض في EDS

Therapy of necrobiotic xanthogranuloma - case series and review of the literature.

التفاصيل البيبلوغرافية
العنوان: Therapy of necrobiotic xanthogranuloma - case series and review of the literature.
المؤلفون: Hansen I; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ghandili S; II. Medical Department and Clinic, Department of Oncology, Hematology and Bone Marrow Transplants with the Section Pulmonology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Abeck F; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Booken N; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schneider SW; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
المصدر: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2023 Nov; Vol. 21 (11), pp. 1315-1318. Date of Electronic Publication: 2023 Oct 09.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Blackwell Country of Publication: Germany NLM ID: 101164708 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1610-0387 (Electronic) Linking ISSN: 16100379 NLM ISO Abbreviation: J Dtsch Dermatol Ges Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Blackwell, 2003-
مواضيع طبية MeSH: Necrobiotic Xanthogranuloma*/diagnosis , Necrobiotic Xanthogranuloma*/therapy , Paraproteinemias*/complications , Paraproteinemias*/pathology , Skin Diseases*/pathology , Histiocytosis, Non-Langerhans-Cell*, Humans ; Chlorambucil
مستخلص: Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.
(© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
References: Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol. 1980;3(3):257-270.
Hilal T, DiCaudo DJ, Connolly SM, Reeder CB. Necrobiotic xanthogranuloma: a 30-year single-center experience. Ann Hematol. 2018;97(8):1471-1479.
Haiduk J, Liebetrau M, Kunz M, et al. Nekrobiotisches Xanthogranulom mit Multiorganbefall bei assoziiertem multiplen Myelom. J Dtsch Dermatol Ges. 2019;17(Suppl 2):16-19.
Tronnier M, Mitteldorf C. Histologic features of granulomatous skin diseases. Part 1: Non-infectious granulomatous disorders. J Dtsch Dermatol Ges. 2015;13(3):211-216.
Luder CM, Nordmann TM, Ramelyte E, et al. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations. J Eur Acad Dermatol Venereol. 2018;32(6):926-934.
Lipsker D. Monoclonal gammopathy of cutaneous significance: review of a relevant concept. J Eur Acad Dermatol Venereol. 2017;31(1):45-52.
Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672-2681.
Nelson CA, Zhong CS, Hashemi DA, et al. A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria. JAMA Dermatol. 2020;156(3):270-279.
Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic xanthogranuloma - a systematic review. J Eur Acad Dermatol Venereol. 2017;31(2):221-235.
Steinhelfer L, Kuhnel T, Jagle H, et al. Systemic therapy of necrobiotic xanthogranuloma: a systematic review. Orphanet J Rare Dis. 2022;17(1):132.
المشرفين على المادة: 18D0SL7309 (Chlorambucil)
تواريخ الأحداث: Date Created: 20231009 Date Completed: 20231113 Latest Revision: 20231114
رمز التحديث: 20231114
DOI: 10.1111/ddg.15195
PMID: 37811744
قاعدة البيانات: MEDLINE
الوصف
تدمد:1610-0387
DOI:10.1111/ddg.15195